ES2080657B1 - Proteasas modificadas. - Google Patents

Proteasas modificadas.

Info

Publication number
ES2080657B1
ES2080657B1 ES9302039A ES9302039A ES2080657B1 ES 2080657 B1 ES2080657 B1 ES 2080657B1 ES 9302039 A ES9302039 A ES 9302039A ES 9302039 A ES9302039 A ES 9302039A ES 2080657 B1 ES2080657 B1 ES 2080657B1
Authority
ES
Spain
Prior art keywords
modified
serin
proteases
modified proteases
thrombolitic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9302039A
Other languages
English (en)
Other versions
ES2080657A1 (es
Inventor
Keith Martyn Dawson
Richard James Gilbert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vernalis R&D Ltd
Original Assignee
BRITISCH BIO TECHNOLOGY LIMITE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BRITISCH BIO TECHNOLOGY LIMITE filed Critical BRITISCH BIO TECHNOLOGY LIMITE
Priority to ES9302039A priority Critical patent/ES2080657B1/es
Publication of ES2080657A1 publication Critical patent/ES2080657A1/es
Application granted granted Critical
Publication of ES2080657B1 publication Critical patent/ES2080657B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SERIN PROTEASAS DE LA SUPERFAMILIA QUIMOTRIPSINA MODIFICADOS DE MANERA QUE MUESTRAN RESISTENCIA A LOS INHIBIDORES DE SERIN PROTEASAS. SI TALES SERIN PROTEASAS MODIFICADAS TIENE PROPIEDADES FIBRINOLITICAS, TROMBOLITICAS, ANTITROMBOTICAS O PROTROMBOTICAS, SON UTILES EN EL TRATAMIENTO DE ENFERMEDADES O TRASTORNOS DE LA COAGULACION DE LA SANGRE.
ES9302039A 1993-09-27 1993-09-27 Proteasas modificadas. Expired - Fee Related ES2080657B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9302039A ES2080657B1 (es) 1993-09-27 1993-09-27 Proteasas modificadas.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9302039A ES2080657B1 (es) 1993-09-27 1993-09-27 Proteasas modificadas.

Publications (2)

Publication Number Publication Date
ES2080657A1 ES2080657A1 (es) 1996-02-01
ES2080657B1 true ES2080657B1 (es) 1996-11-01

Family

ID=8283159

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9302039A Expired - Fee Related ES2080657B1 (es) 1993-09-27 1993-09-27 Proteasas modificadas.

Country Status (1)

Country Link
ES (1) ES2080657B1 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2007364A1 (en) * 1989-01-17 1990-07-17 David J. Livingston Gene sequences encoding modified residues situated in the protease domain of tpa
US5304482A (en) * 1989-03-06 1994-04-19 The Board Of Regents Of The University Of Texas System Serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors
WO1990010649A1 (en) * 1989-03-06 1990-09-20 The Board Of Regents Of The University Of Texas System Serpin resistant chymotrypsin superfamily proteases, particularly pai-1 resistant +-pa, complementary inhibitor mutants; compositions; genes; expression
GB8927722D0 (en) * 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids

Also Published As

Publication number Publication date
ES2080657A1 (es) 1996-02-01

Similar Documents

Publication Publication Date Title
ES2151610T3 (es) Sintesis de polimero.
PT925319E (pt) Polimeros de triazina e sua utilizacao em dispositivos electroluminescentes
MX9301634A (es) Quinuclidinas peptidicas.
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
NO984452L (no) FremgangsmÕte for Õ bestemme steins kompresjonsmotstand
DE69033626D1 (de) Mittel zur Hemmung des Komplementsystems hergestellt aus Fucanen aus braunen Algen
CY1111863T1 (el) Αντισωματα εναντιον υποδοχεα θανατου 4 (dr4) και χρησεις αυτων
DE3853340D1 (de) Dien-Blockpolymer und Polymerzusammensetzung.
DK1029921T3 (da) Serpinresistent t-PA, mutanter, gener
DE69229552D1 (de) Hemmstoffe für kathepsin-g und elastase zur verhütung von bindegewebsabbau
SE9604815D0 (sv) A metod of diagnosis
ES2161920T3 (es) Peliculas a base de poliamida y polimeros de bloques poliamidas y bloques polieteres.
EE05497B1 (et) Polüpeptiid, lahustuv CRAM-1 polüpeptiid, polünukleotiid ja antikeha
ES2093458T3 (es) Procedimiento para la obtencion de 1,1,1,3,3-pentafluorpropano.
FI913391A0 (fi) Foerfarande foer detektering av smaocellcarcinom och anvaendning av acylpeptidhydrolas och denna kodande sekvenser.
NO963487L (no) Isolerte, tyrosinaseavledete peptider, samt anvendelser derav
DE69531459D1 (de) Elatase-inhibitoren
DK1040191T3 (da) RANTES-mutanter og terapeutiske anvendelser heraf
FR2709129A1 (fr) Polymères comprenant des séquences polyéther et des séquences polyamides.
DK0929299T3 (da) Substituerede 1,2,3,4-tetrahydro-2-dibenzofuranaminer og 2-aminocyclohepta-(b)benzofuraner
CY1106363T1 (el) Χρηση του ενepγοποιημενου παραγοντα πηξης vii για την αγωγη των επαγομενων απο θρομβολυτικη θepαπεια μειζονων αιμορραγιων
ES2065472T3 (es) Composiciones de betun.
DK0563144T3 (da) Diagnosticering af malign hypertermi hos svin
ATE335027T1 (de) Kernhydrierte blockcopolymere mit assymetrischem aufbau
EP0651020A3 (en) Thermosetting organopolysiloxane mass.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19930927

Kind code of ref document: B1

Effective date: 19930927

PC2A Transfer of patent

Owner name: BRITISH BIOTECH PHARMACEUTICALS LIMITED

FD2A Announcement of lapse in spain

Effective date: 20180806